RevOpsis Therapeutics, Inc. — Form D
RevOpsis Therapeutics, Inc. of SPRINGFIELD, IL, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-24. The offering totals $18.0M, of which $100K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-08-24
- Form: D
- Accession: 0001939796-22-000003
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $18.0M
- Amount sold: $100K
- Remaining: $17.9M
- Minimum investment: $25K
- Investors: 1
- Date of first sale: 2022-08-19
- Revenue range: Decline to Disclose
- SEC file number: 021-456854
Issuer
- Name: RevOpsis Therapeutics, Inc.
- CIK: 0001939796
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 4109 CHANDLERWOOD, SPRINGFIELD, IL, 62711
- Phone: 6462215178
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Jeff P Olson | Director | Springfield, IL |
| Ram P Palanki | Director | Springfield, IL |
| Ram P Palanki | Executive Officer | Springfield, IL |
| Ramanath Bhandari | Promoter | Tampa, FL |
| Ram Palanki | Director | Tampa, FL |
| Ram Palanki | Executive Officer | Tampa, FL |
| Jeff Olson | Director | Tampa, FL |
| Ramanath Bhandari | Director | Tampa, FL |
| Ramanath Bhandari | Executive Officer | Tampa, FL |
Other filings by this issuer (3)
More